These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 541367)

  • 1. Measurement of mephenytoin (3-methyl-5-ethyl-5-phenylhydantoin) and its demethylated metabolite by selective ion monitoring.
    Yonekawa W; Kupferberg HJ
    J Chromatogr; 1979 Jun; 163(2):161-7. PubMed ID: 541367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The metabolism of 3-methyl-5-ethyl-5-phenylhydantoin (mephenytoin) to 5-ethyl-5-phenylhydantoin (Nirvanol) in mice in relation to anticonvulsant activity.
    Kupferberg HJ; Yonekawa W
    Drug Metab Dispos; 1975; 3(1):26-9. PubMed ID: 234831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A major pathway of mephenytoin metabolism in man. Aromatic hydroxylation to p-hydroxymephenytoin.
    Küpfer A; Brilis GM; Watson JT; Harris TM
    Drug Metab Dispos; 1980; 8(1):1-4. PubMed ID: 6102023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct enantiomeric resolution of mephenytoin and its N-demethylated metabolite in plasma and blood using chiral capillary gas chromatography.
    Wedlund PJ; Sweetman BJ; McAllister CB; Branch RA; Wilkinson GR
    J Chromatogr; 1984 Apr; 307(1):121-7. PubMed ID: 6725478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacology of mephenytoin and ethotoin.
    Troupin AS; Friel P; Lovely MP; Wilensky AJ
    Ann Neurol; 1979 Nov; 6(5):410-4. PubMed ID: 42344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gas-chromatographic determination of mephenytoin and desmethylmephenytoin, after off-column alkylation.
    Raisys VA; Zebelman AM; MacMillan SF
    Clin Chem; 1979 Jan; 25(1):172-5. PubMed ID: 761360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of mephenytoin metabolites in human urine by gas chromatography and mass spectrometry.
    Lynn RK; Bauer JE; Gordon WP; Smith RG; Griffin D; Thompson RM; Jenkins R; Gerber N
    Drug Metab Dispos; 1979; 7(3):138-44. PubMed ID: 38083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disposition of mephenytoin and its metabolite, nirvanol, in epileptic patients.
    Theodore WH; Newmark ME; Desai BT; Kupferberg HJ; Penry JK; Porter RJ; Yonekawa WD
    Neurology; 1984 Aug; 34(8):1100-2. PubMed ID: 6431315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Determination of phenobarbital, mephenytoin and diphenylhydantoin in the surveillance of anticonvulsant treatment].
    Maitrot B; Hue G; Canonne MA; Rocher A; Landriau N
    Ann Biol Clin (Paris); 1976; 34(2):107-12. PubMed ID: 9890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mephenytoin: a reappraisal.
    Troupin AS; Ojemann LM; Dodrill CB
    Epilepsia; 1976 Dec; 17(4):403-14. PubMed ID: 1001284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-ethyl-5-phenylhydantoin N-glucuronide, the major urinary metabolite of 5-ethyl-5-phenylhydantoin (Nirvanol) in the dog.
    Maguire JH; Butler TC; Dudley KH
    Drug Metab Dispos; 1982; 10(6):595-8. PubMed ID: 6130906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of in vivo drug metabolism to stereoselective fetal hydantoin toxicology in mouse: evaluation of mephenytoin and its metabolite, nirvanol.
    Wells PG; Küpfer A; Lawson JA; Harbison RD
    J Pharmacol Exp Ther; 1982 Apr; 221(1):228-34. PubMed ID: 7062285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enantiospecific separation and quantitation of mephenytoin and its metabolites nirvanol and 4'-hydroxymephenytoin in human plasma and urine by liquid chromatography/tandem mass spectrometry.
    Jansson B; Elsherbiny D; Simonsson US
    Rapid Commun Mass Spectrom; 2006; 20(3):463-72. PubMed ID: 16395737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for the epoxide-diol pathway in the biotransformation of mephenytoin.
    Gerber N; Thompson RM; Smith RG; Lynn RK
    Epilepsia; 1979 Jun; 20(3):287-94. PubMed ID: 446437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of R-enantiomeric normephenytoin during chronic administration in epileptic patients.
    Bourgeois BF; Küpfer A; Wad N; Egli M
    Epilepsia; 1986; 27(4):412-8. PubMed ID: 3720699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of mephenytoin metabolites in the dog.
    Karlaganis G; Küpfer A; Bircher J; Schlunegger UP; Gfeller H; Bigler P
    Drug Metab Dispos; 1980; 8(3):173-7. PubMed ID: 6104582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereochemical aspects of the metabolism of 5-ethyl-5-phenylhydantoin (Nirvanol) in the dog.
    Maguire JH; Kraus BL; Butler TC; Dudley KH
    Drug Metab Dispos; 1981; 9(5):393-401. PubMed ID: 6117436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The metabolic conversion of 3-methyl-5-ethyl-5-phenyl hydantoin (mesantoin) and of 5-ethyl-5-phenyl hydantoin (nirvanol) to 5 - ethyl -5- (p-hydroxyphenyl) hydantoin.
    BUTLER TC
    J Pharmacol Exp Ther; 1956 Jun; 117(2):160-5. PubMed ID: 13332557
    [No Abstract]   [Full Text] [Related]  

  • 19. Increased systemic availability of drugs during acute ethanol intoxication: studies with mephenytoin in the dog.
    Zysset T; Preisig R; Bircher J
    J Pharmacol Exp Ther; 1980 Apr; 213(1):173-8. PubMed ID: 7188964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assay of mephenytoin metabolism in human liver microsomes by high-performance liquid chromatography.
    Meier UT; Kronbach T; Meyer UA
    Anal Biochem; 1985 Dec; 151(2):286-91. PubMed ID: 4096368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.